Cannabis Industry Applauds President Biden's Commitment to Reschedule Marijuana During Annual Visit to Capitol Hill

WASHINGTON, D.C. - May 16, 2024 (Investorideas.com Newswire) Today, President Joe Biden announced that the Department of Justice is reclassifying cannabis from its Schedule I status in the Controlled Substances Act. The administration is poised to initiate the rulemaking process that will open a 60 day public comment period before the change is made official.

This announcement comes just minutes after the National Cannabis Industry Association (NCIA) concluded its 12th Annual Cannabis Industry Lobby Days in Washington, D.C., the largest advocacy event for the legal industry.

Over the course of the two-day event, more than 100 cannabis business professionals held citizen lobbying meetings with congressional offices to discuss the positive economic and social impact that regulating cannabis markets has already had on states with modern marijuana laws. Participants advocated for federal reforms that need to be enacted after rescheduling, such as legislation that would allow banks to more easily do business with the legal cannabis industry and broader reforms that would regulate cannabis like alcohol.

Rescheduling, while hailed as an incremental win for the legal cannabis industry, would not legalize marijuana or harmonize federal law with the laws that allow for either medical or adult-use cannabis sales in 38 states nor does it right the wrongs of decades of misguided prohibition policies.

"On behalf of thousands of legal businesses operating across the country, we commend President Biden for taking this important first step toward a more rational marijuana policy. Now it's time for Congress to enact legislation that would protect our industry, uphold public safety, and advance the will of the voters who overwhelmingly support making cannabis legal for adults," said Aaron Smith, NCIA CEO & Co-founder. "Rescheduling alone does not fix our nation's state and federal cannabis policy conflict. Only Congress can enact the legislation needed to fully respect the states and advance the will of the vast majority of voters who support legal cannabis."

Reclassifying marijuana from Schedule I to Schedule III in the Controlled Substances Act would provide tax parity for the cannabis industry by ensuring legal businesses would no longer be subject to an arcane provision of the U.S. tax code -- Section 280E -- that prohibits deductions associated with "drug trafficking."

NCIA will be submitting public comments during the rulemaking period on behalf of the hundreds of small businesses it represents in the legal cannabis industry. In addition to calling on legislation that would carve out a new regulatory pathway for cannabis products, the association supports legislation that would provide retroactive relief for lawful businesses with tax liability associated with Section 280E.

Laws to make cannabis legal for adults have passed in 24 states as well as the District of Columbia and the territories of CNMI and Guam, and 38 states as well as several territories have comprehensive medical cannabis laws.

Just over half of Americans live in a state that has made cannabis legal for adults over 21 and three out of four Americans live in a state that has legalized cannabis for medical use. A November 2023 Gallup survey found that 70% of Americans support making cannabis legal for adults and a recent Pew Research Center poll found that less than 10% of Americans still support marijuana prohibition.

The National Cannabis Industry Association (NCIA) is the largest cannabis trade association in the U.S. and the only organization representing small and independent cannabis-related businesses at the national level. NCIA promotes the growth of a responsible, sustainable, and inclusive cannabis industry and works for a favorable social, economic, and regulatory environment for that industry throughout the United States.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Buy a cannabis guest post on Investorideas.com